Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC reduced its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 8.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,728 shares of the real estate investment trust’s stock after selling 8,208 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Sabra Healthcare REIT were worth $1,544,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. M&T Bank Corp raised its stake in Sabra Healthcare REIT by 2.1% during the first quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust’s stock worth $905,000 after purchasing an additional 1,059 shares during the period. Cerity Partners LLC acquired a new stake in shares of Sabra Healthcare REIT during the 1st quarter worth $189,000. State of Michigan Retirement System raised its position in shares of Sabra Healthcare REIT by 1.1% in the 1st quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust’s stock worth $990,000 after buying an additional 600 shares during the period. Ballentine Partners LLC acquired a new position in Sabra Healthcare REIT in the first quarter valued at $218,000. Finally, Stephens Inc. AR boosted its holdings in Sabra Healthcare REIT by 2.5% in the first quarter. Stephens Inc. AR now owns 42,492 shares of the real estate investment trust’s stock valued at $742,000 after acquiring an additional 1,044 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Up 0.4%

NASDAQ SBRA opened at $19.16 on Wednesday. The stock has a market cap of $4.78 billion, a P/E ratio of 25.21, a PEG ratio of 1.10 and a beta of 0.84. The company’s fifty day simple moving average is $18.40 and its 200-day simple moving average is $18.29. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. During the same quarter in the previous year, the firm posted $0.37 EPS. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 28th. Investors of record on Monday, November 17th will be paid a $0.30 dividend. The ex-dividend date is Monday, November 17th. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. Sabra Healthcare REIT’s payout ratio is 166.67%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SBRA. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Wells Fargo & Company dropped their target price on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. JMP Securities lifted their price target on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 6th. Cantor Fitzgerald initiated coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective for the company. Finally, Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research report on Tuesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $20.75.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.